Scientists have deciphered how an activated catalyst breaks down the strong carbon-hydrogen bonds in potent greenhouse gas methane, according to a study published in Science. Using advanced X-ray technology and quantum-chemical calculations, they tracked the electron exchange between the catalyst and the methane molecule, paving the way for developing more efficient catalysts to convert harmful gases into useful chemicals.
The use of short flashes of X-ray light brings scientists one big step closer to developing better catalysts to transform the greenhouse gas methane into a less harmful chemical. The result, published in the journal Science, reveals for the first time how carbon-hydrogen bonds of alkanes break and how the catalyst works in this reaction.
Methane, one of the most potent greenhouse gases, is being released into the atmosphere at an increasing rate by livestock farming as well as the continuing unfreezing of permafrost. Transforming methane and longer-chain alkanes into less harmful and in fact useful chemicals would remove the associated threats, and in turn make a huge feedstock for the chemical industry available. However, transforming methane necessitates as a first step the breaking of a C-H bond, one of the strongest chemical linkages in nature.
The research was led by scientists from Uppsala University in collaboration with the Paul Scherrer Institute in Switzerland, Stockholm University, Hamburg University and the European XFEL in Germany. For the first time, the scientists were able to directly watch the catalyst at work and reveal how it breaks those C-H bonds.

Raphael Jay, Researcher at the Department of Physics and Astronomy, Uppsala University. Credit: Mikael Wallerstedt
In two experiments conducted at the Paul Scherrer Institute in Switzerland, the researchers were able to follow the delicate exchange of electrons between a rhodium catalyst and an octane C-H group as it gets broken. Using two of the most powerful sources of X-ray flashes in the world, the X-ray laser SwissFEL and the X-ray synchrotron Swiss Light Source, the reaction could be followed all the way from the beginning to the end. The measurements revealed the initial light-induced activation of the catalyst within 400 femtoseconds (0.0000000000004 seconds) to the final C-H bond breaking after 14 nanoseconds (0.000000014 seconds).
"The time-resolved X-ray absorption experiments we performed are only possible at large-scale facilities like SwissFEL and the Swiss Light Source, which provide extremely bright and short X-ray pulses. The catalyst is immersed in a dense octane solution, but by taking the perspective of the metal, we could specifically pick the one C-H bond out of hundreds of thousands which is made to break," explains Raphael Jay, Researcher at Uppsala University and lead experimentalist of the study.

Philippe Wernet, Professor at the Department of Physics and Astronomy, Uppsala University. Credit: Mikael Wallerstedt
To interpret the complex experimental data, theoreticians from Uppsala University and Stockholm University teamed up and performed advanced quantum-chemical calculations.
"Our calculations allow us to clearly identify how electronic charge flows between the metal catalyst and the C-H group in just the right proportion. We can see how charge flowing from the metal onto the C-H bond glues the two chemical groups together. Charge flowing in the opposite direction instead acts as a scissor that eventually breaks the C and the H atom apart," explains Ambar Banerjee, Postdoctoral researcher at Uppsala University and lead theoretician of the study.
The study solves a forty-year-old mystery about how an activated catalyst can actually break strong C-H bonds by carefully exchanging fractions of electrons and without the need for huge temperatures or pressures. With their new tool to hand, the researchers next want to learn how to direct the flow of electrons to help develop better catalysts for the chemical industry in order to make something useful out of methane and other alkanes.
Facts
The study builds on the pioneering work of grandfather, father and son Manne, Kai, and Per Siegbahn.
Manne Siegbahn (Uppsala University), who received the Nobel Prize in Physics in 1924, pioneered how different elements can be distinguished by X-rays.
Kai Siegbahn (Uppsala University), who received the Nobel Prize in Physics in 1981, pioneered how different chemical environments of the same element can be distinguished by X-rays.
Per Siegbahn (Stockholm University) theoretically predicted the concerted exchange of electronic charge required for breaking a C-H bond.
Reference: "Tracking C-H activation with orbital resolution" by Raphael M. Jay, Ambar Banerjee, Torsten Leitner, Ru-Pan Wang, Jessica Harich, Robert Stefanuik, Hampus Wikmark, Michael R. Coates, Emma V. Beale, Victoria Kabanova, Abdullah Kahraman, Anna Wach, Dmitry Ozerov, Christopher Arrell, Philip J. M. Johnson, Camelia N. Borca, Claudio Cirelli, Camila Bacellar, Christopher Milne, Nils Huse, Grigory Smolentsev, Thomas Huthwelker, Michael Odelius and Philippe Wernet, 1 June 2023, Science.
DOI: 10.1126/science.adf8042
News
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]















